search
News & Developments
ViewView
Press Releases

DSK Legal advised CMA CGM S.A. (“CMA CGM”)in relation to the Indian law components of its strategic partnership with Stonepeak Partners LP

DSK Legal assisted and advised CMA CGM S.A. (“CMA CGM”), the world’s third-largest container shipping group, in relation to the Indian law components of its strategic partnership with Stonepeak Partners LP, a leading alternative investment firm specializing in infrastructure and real assets.  Under the terms of the agreement, Stonepeak acquired a 25% (twenty-five per cent) minority stake in United Ports LLC for USD 2.4 billion. The deal further includes a commitment for up to USD 3.6 billion in additional investment, making it one of the most significant infrastructure transactions in the maritime sector. The transaction establishes United Ports LLC to consolidate 10 (ten) strategically located port terminals across 6 (six) countries, viz. Los Angeles Fenix Marine Services (United States), Port Liberty terminals in New York and Bayonne (United States), Santos terminals (Brazil), CSP Valencia and CSP Bilbao (Spain), Terminal Maritima del Guadalquivir (Spain), TTI Algeciras (Spain), Nhava Sheva Freeport Terminal (India), CMA CGM Kaohsiung Terminal (Taiwan), and Gemalink in Cai Mep (Vietnam). In India, the transaction includes the Nhava Sheva Freeport Terminal (“NSFT”) at Jawaharlal Nehru Port, Mumbai, which is India’s first deep-draft, automated container terminal, significantly enhancing the country’s container handling capacity, efficiency, and global trade connectivity. DSK Legal advised CMA CGM S.A. on the Indian law aspects of the transaction, including: (i) conducting legal due diligence; (ii) advising on the implications of global consolidation for Indian operations and corporate structures; (iii) advising on key government and security approvals and clearances; and (iv) advising on rights and obligations under the relevant project and financing agreements. Deal value: USD 6 Bn The team at DSK Legal, representing CMA CGM S.A., comprised of Mr. Manhar Gulani (Principal Associate), Ms. Mala Mehto (Principal Associate), Mr. Abhikalpa Ghosh (Senior Associate), Mr. Vedant Sinha (Associate), and Mr. Brijesh Ranjan Sahoo (Associate). Mr. Avinash Kumar Khard (Partner) and Mr. Harvinder Singh (Partner) acted as the lead engagement partners, and Mr. Anjan Dasgupta (Partner) acted as the relationship partner for CMA CGM S.A. and provided strategic inputs on the transaction. Other advisor(s) assisting on the Transaction included Willkie Farr & Gallagher LLP.
DSK Legal - February 9 2026
Press Releases

DMD Advocates Advises Maschinenfabrik Reinhausen GmbH on the Acquisition of Shares in KVTEK Power Systems Private Limited

DMD Advocates advised Maschinenfabrik Reinhausen GmbH (MR), a German-based engineering group, on legal due diligence and transaction documentation in connection with the acquisition of an equity stake in KVTEK Power Systems Private Limited, an India-based manufacturer of power transformers, distribution and instrument transformers, high-voltage cables, and switchgear. The acquisition strengthens MR’s position in high-voltage testing and measurement and supports the strategic expansion of its subsidiary, HIGHVOLT Prüftechnik Dresden GmbH, which operates in the same technology segment. The transaction was led by Vihang Virkar (Lead Partner, Mumbai Corporate Practice Group), along with Monika Deshmukh (Partner), Pooja Shah (Principal Associate), Advait Borade (Associate), Disha Jain (Associate), Vanshikha Choraria (Associate), and Nardeep Chawla (Associate).
DMD Advocates - February 5 2026
Press Releases

TLH, Advocates & Solicitors Announces the Joining of Mathew George as Of Counsel

TLH, Advocates & Solicitors is pleased to announce that Mathew George has joined the Firm as Of Counsel, strengthening its competition law and regulatory practice. Mathew is a seasoned competition and regulatory lawyer with nearly a decade of experience advising on antitrust enforcement, merger control, digital markets regulation, and complex regulatory litigation. He has been involved in a wide range of contentious competition matters before the Competition Commission of India (CCI), the National Company Law Appellate Tribunal (NCLAT), various High Courts, and the Supreme Court of India. He has worked on over 25 merger notifications, including Form I, Form II, and Green Channel filings, across sectors such as technology, manufacturing, infrastructure, financial services, and private equity. His practice includes handling high-stakes investigations, including cartel defence, vertical restraints, and abuse of dominance matters, spanning the entire life cycle of competition proceedings. Mathew has advised a diverse clientele comprising leading global technology companies, multinational conglomerates, industry associations, private equity funds, and sovereign funds. He also brings experience in public policy development, having contributed to and represented submissions before Parliamentary Committees and the CCI, including on India’s proposed Digital Competition Bill and the Competition Law Review Committee.
TLH, Advocates & Solicitors - February 5 2026
Insolvency and Restructuring; Disputes Resolution

Juris Corp successfully represented and advised the Committee of Creditors in the Corporate Insolvency Resolution Process of Sevenhills Healthcare Pvt. Ltd.

Deal Summary & Significance: SevenHills Healthcare Pvt. Ltd. (“CD”) was admitted into the Corporate Insolvency Resolution Process (“CIRP”) on 13th March 2018 upon an application filed by Axis Bank. The CD owned two key healthcare assets: i) SevenHills Hospital, Mumbai (“Mumbai Hospital”), and ii) SevenHills Hospital, Visakhapatnam (“Vizag Hospital”). The initial resolution plan submitted by Dr. B.R. Shetty through Shetty’s New Medical Centre Pvt. Ltd. (“SNMC Resolution Plan”) was challenged by the Municipal Corporation of Greater Mumbai (“MCGM”) up to the Hon’ble Supreme Court of India (“Supreme Court”), since the Mumbai Hospital of the CD stands on land owned by MCGM. Supreme Court allowed MCGM’s appeal and rejected the SNMC Resolution Plan, holding that the mandatory No Objection Certificate (NOC) under the Mumbai Municipal Corporation Act, 1888 (“MMC Act”) had not been obtained prior to the creation of security interest over land owned by MCGM. In 2020, amid the unprecedented Covid‑19 pandemic, MCGM requisitioned the Mumbai Hospital as a dedicated Covid facility under the Disaster Management Act, 2005. The requisition and the wider public health emergency led to repeated extensions of the CIRP timeline, significantly delaying progress. Despite these delays, the CIRP continued to move forward. The Committee of Creditors (“CoC”) resolved to issue a fresh Invitation for Expression of Interest (“EoI”) for asset‑wise CIRP under Regulation 36B(6A) of the CIRP Regulations, a provision that enables inviting asset‑specific resolution plans when no feasible plan is received for the corporate debtor as a whole. As the process advanced, MCGM initiated parallel litigation seeking to exclude the Mumbai Hospital from the CD’s asset pool. During this period, multiple proceedings were also undertaken to secure MCGM’s cooperation and prevent termination of the subsisting agreement between the parties. Amidst these challenges, a fresh process was initiated inviting resolution plans under two separate categories: i) Category 1: Vizag Hospital; and ii) Category 2: Mumbai Hospital together with the CD as a going concern. In June 2024, the Adjudicating Authority (“AA”) approved the resolution plan for Category 1 and dismissed MCGM’s objections to the plan. In December 2025, MCGM granted the requisite NOC to the resolution plan submitted by Capri Global Holdings Private Limited for Category 2. The plan subsequently received 100% approval from the CoC and was approved by the AA on 19th February 2026. In a healthcare‑focused CIRP shaped by multiple disputes, extensive litigation, and pandemic‑related disruption, Juris Corp consistently advised and represented the CoC, ultimately maximising value for the CD and strengthening recoveries for its stakeholders. Significance of the Matter This is a significant asset‑wise Corporate Insolvency Resolution Process outcome in the healthcare sector, shaped by extensive litigation and prolonged pandemic‑related disruption. The resolution achieved demonstrates robust creditor‑led decision‑making and successful navigation of regulatory requirements, culminating in value maximisation and enhanced stakeholder recoveries. Law Firms Involved: Trilegal for Resolution Professional, EY (Ernst & Young); Shardul Amarchand Mangaldas for MCGM; Saraf and Partners for Successful Resolution Applicant, Practice Area: Insolvency and Restructuring; Disputes Resolution. Deal Value: 1500 Crores. Deal Closing Date: 19th January 2026. Team Involved: Mr. Jayesh H (Senior Partner), Ms. Jinal Shah (Associate Partner), Ms. Palak Nenwani (Principal Associate), Mr. Ronit Chopra (Associate).
Juris Corp - February 5 2026